Dima Karbala Hamadeh
About Dima Karbala Hamadeh
Dima Karbala Hamadeh is the Market Access Strategy Director at Bristol Myers Squibb in Princeton, New Jersey, with extensive experience in global pricing, market access, and payer research in the pharmaceutical industry.
Professional Title and Current Role
Dima Karbala Hamadeh currently holds the position of Market Access Strategy Director at Bristol Myers Squibb. Based in Princeton, New Jersey, she is responsible for leading strategic initiatives to ensure market access for the company's products.
Previous Positions at Bristol Myers Squibb
Prior to her current role, Dima worked as Associate Director World Wide Value Access & Payer Research at Bristol Myers Squibb from 2018 to 2020. During this period, she played a significant role in payer research and value access initiatives to support the market entry of new products.
Roles at Amgen
Dima Karbala Hamadeh has extensive experience at Amgen, having held multiple roles such as Global Pricing and Market Access (2017-2018), Business Analytics and Insights Early Oncology Pipeline (2015-2017), and Strategy & Business Performance Senior Manager (2012-2015) in Thousand Oaks, California. In these positions, she contributed to the pricing strategies, business analytics, and overall performance management for various therapeutic areas.
Experience in Strategic Consulting
From 2007 to 2012, Dima worked as an Associate at Booz & Company in Beirut. During her tenure, she was involved in strategic consulting projects across numerous industries, gaining valuable insights and experience in business strategy and performance optimization.
Education Background
Dima studied at Harvard University Kennedy School of Government, earning a Master’s degree in Development Economics and International Development from 2009 to 2011. She also holds a Bachelor’s degree in Economics from the American University of Beirut, obtained between 2003 and 2006.